Cannabis and Cannabinoids in Multiple Sclerosis: From Experimental Models to Clinical Practice—A Review
Sign Up to like & getrecommendations! Published in 2022 at "American Journal of Therapeutics"
DOI: 10.1097/mjt.0000000000001568
Abstract: Background: As far as 80% of people diagnosed with multiple sclerosis (MS) experience disabling symptoms in the course of the disease, such as spasticity and neuropathic pain. As first-line symptomatic therapy is associated with important… read more here.
Keywords: cannabinoids multiple; experimental models; cannabis cannabinoids; multiple sclerosis ... See more keywords
Research progress of statins on immune regulation of multiple sclerosis and experimental allergic encephalomyelitis.
Sign Up to like & getrecommendations! Published in 2022 at "Allergologia et immunopathologia"
DOI: 10.15586/aei.v50i6.658
Abstract: OBJECTIVE The aim of this study is to summarize studies on statins used to treat multiple sclerosis (MS) and experimental allergic encephalomyelitis (EAE) and its underlying mechanisms. METHODS We searched some representing databases. Some studies… read more here.
Keywords: multiple sclerosis; allergic encephalomyelitis; sclerosis experimental; experimental allergic ... See more keywords
Role of Anti-Osteopontin Antibodies in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis
Sign Up to like & getrecommendations! Published in 2017 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2017.00321
Abstract: Osteopontin (OPN) is highly expressed in demyelinating lesions in multiple sclerosis (MS) and experimental autoimmune encephalomyelitis (EAE). OPN is cleaved by thrombin into N- (OPN-N) and C-terminal (OPN-C) fragments with different ligands and functions. In… read more here.
Keywords: sclerosis experimental; anti; multiple sclerosis; autoimmune encephalomyelitis ... See more keywords